What does trametinib target drug treat and how long will the side effects last?

Trametinib (Trametinib) is mainly used to treat advanced melanoma, non-small cell lung cancer, anaplastic thyroid cancer, solid tumors, low-grade malignant glioma, etc. with BRAF V600E or V600K mutations. It belongs to the MEK inhibitor class of drugs and inhibits the growth and spread of tumor cells by blocking the activity of MEK1/2 protein kinase. For these specific types of cancer, when they have the BRAF V600E or V600K gene mutation, trametinib is effective at inhibiting tumor progression and spread.

As for side effects, each person's body may react differently, but they usually appear within a few days to a few weeks of starting treatment. Common side effects include rash, fatigue, nausea, headache, muscle pain, joint pain, stomatitis, etc. Generally, most side effects disappear within a few days after stopping the medication. Some patients' reactions may last longer, so it is recommended to closely monitor their physical condition while using trametinib and seek medical advice promptly if they feel unwell.

The original drug of Trametinib has been launched in China and is included in the scope of medical insurance. Only patients who meet the indications can choose to reimburse. The price of 2 mg*30 tablets is more than RMB 10,000. The original drug of Trametinib sold overseas is priced at more than RMB 7,000 (the price may fluctuate due to the exchange rate). There are also generic trametinib drugs produced in other countries overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 2mg*30 tablets produced by a Laos pharmaceutical factory is more than 2,000 yuan (the price may fluctuate due to the exchange rate), and the price is relatively cheap.